RSS   Newsletter   Contact   Advertise with us
Post Online Media

PhaseRx appoints Peggy Phillips to board of directors

PhaseRxPhaseRx, Inc., a biopharmaceutical company, announced the appointment of Peggy Phillips to the company's board of directors.

Ms. Phillips served as the chief operating officer for Immunex from 1999 until 2002 when the company was acquired by Amgen. During her 16-year career at Immunex, she held positions of increasing responsibility in research, development, manufacturing, sales, and marketing.

As general manager for Enbrel, she was responsible for clinical development, process development and regulatory affairs, as well as the launch, sales and marketing of the product.

Prior to joining Immunex, Ms. Phillips worked at Miles Laboratories for 10 years.

Ms. Phillips previously served on the boards of Immunex Corporation (1996-2002), the U.S. Naval Academy Foundation (2002-2010), Western Wireless (2004-2005), Portola Pharmaceuticals (2006-2013), and Tekmira Pharmaceuticals (2014-2015). She currently serves on the board of Dynavax Technologies.

She holds a B.S. and an M.S. in microbiology from the University of Idaho. She will be replacing Richard Ulevitch, Ph.D., of 5AM Ventures, who is resigning from the board.


 LATEST MOVES FROM Washington 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy